Search Results 251-260 of 16998 for pharmacogenetics
Primary biliary cholangitis and primary sclerosing cholangitis are rare chronic and progressive cholestatic liver diseases that contribute to hepatic failure ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest stories.
The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...
Collaborators. Dr. Lazaridis is involved in several research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators.
In one study, she investigates a series of biomarkers related to the initial treatment for patients with estrogen receptor-positive, or ER+, breast cancer with ...
Science Saturday: Dispelling the hype of stem cell interventions. Susan Buckles. October 23, 2021. Nurses think about suicide more than other workers ...
The primary aim of this study is to establish the practicality of using two novel imaging modalities for the assessment of biomechanical properties of the aorta ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.